GRHL2 levels correlated positively with CDH1 (E-cadherin) levels and negatively with ZEB1 in the CCLE dataset and TCGA datasets from breast cancer, ovarian cancer and colorectal cancer (Figure 1). This evidence concerns the gene CDH1 and ovarian carcinoma.